See what CanVECTOR members are publishing to advance the field of venous thromboembolism
Publications since 2016 that are linked to venous thromboembolism and/or anticoagulant therapy

Publications for Susan Kahn

Updated daily

Back to Member List

#	PubMedId	Deleted	Publication
	42079674	0	Asady E, Jelsness-Jorgensen LP, Ghanima W, et al. Item generation for a new disease-specific health-related quality of life questionnaire in patients with deep vein thrombosis: an international multicenter study. Res Pract Thromb Haemost. 2026 Mar 25;10(3):103443. doi: 10.1016/j.rpth.2026.103443. eCollection 2026 Mar.
	42058833	0	Mai V, Martens ESL, Righini M, et al. Patterns of presentation of suspected and confirmed recurrent venous thromboembolism in patients with prior venous thromboembolism. Res Pract Thromb Haemost. 2026 Mar 25;10(3):103442. doi: 10.1016/j.rpth.2026.103442. eCollection 2026 Mar.
	41972998	0	Vedantham S, Kahn SR, Marston WA, et al. Endovascular Therapy for Post-Thrombotic Syndrome - A Randomized Trial. N Engl J Med. 2026 Apr 13. doi: 10.1056/NEJMoa2519001.
	41812192	0	Castellucci LA, Chen VM, Kovacs MJ, et al. Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism. N Engl J Med. 2026 Mar 12;394(11):1051-1060. doi: 10.1056/NEJMoa2510703.
	41407160	0	Betensky M, Mosha M, Ashour D, et al. Post-Thrombotic Syndrome (PTS)-Related Chronic Limb Pain in Children: Findings from the Kids-DOTT Multinational Trial. J Thromb Haemost. 2025 Dec 15:S1538-7836(25)00895-5. doi: 10.1016/j.jtha.2025.11.018.
	40769433	0	Omar D, Kovacs MJ, Lazo-Langner A, et al. Racial Disparities in the Incidence and Risk Factors for Major Bleeding during Extended Anticoagulant Therapy for Venous Thromboembolism. J Thromb Haemost. 2025 Aug 4:S1538-7836(25)00489-1. doi: 10.1016/j.jtha.2025.07.026.
	40765707	0	Karsanji D, King JA, Godley J, et al. Evaluating research collaboration networks among venous thromboembolism researchers before and during the COVID-19 pandemic. Blood Vessel Thromb Hemost. 2024 Feb 24;1(1):100004. doi: 10.1016/j.bvth.2024.100004. eCollection 2024 Mar.
	40578691	0	Mai V, Martens ESL, Righini M, et al. Performance of clinical decision rules in patients presenting with suspected recurrent venous thromboembolism: a multicenter prospective cohort study. J Thromb Haemost. 2025 Jun 25:S1538-7836(25)00408-8. doi: 10.1016/j.jtha.2025.06.019.
	40216708	0	Makedonov I, Kapitanski L, Giai J, et al. Treatment of isolated distal deep vein thrombosis: an international survey of healthcare professionals. J Thromb Thrombolysis. 2025 Apr 11. doi: 10.1007/s11239-025-03091-5.
	39649131	0	Shih J, Gu CS, Vedantham S, et al. Impact of self-reported race on Villalta Scale postthrombotic syndrome scores and correlation with venous disease-specific quality of life: an exploratory analysis of the Acute Venous Thrombosis: Thrombus Removal with Adjunctive Catheter-Directed Thrombolysis Trial. Res Pract Thromb Haemost. 2024 Oct 29;8(8):102609. doi: 10.1016/j.rpth.2024.102609. eCollection 2024 Nov.
	38938844	0	Godoy LC, Neal MD, Goligher EC, et al. Heparin Dose Intensity and Organ Support-Free Days in Patients Hospitalized for COVID-19. JACC Adv. 2024 Jan 26;3(3):100780. doi: 10.1016/j.jacadv.2023.100780. eCollection 2024 Mar.
	38030465	0	Gal GL, Agnelli G, Darius H, et al. Event rates and risk factors for venous thromboembolism and major bleeding in a population of hospitalized adult patients with acute medical illness receiving enoxaparin thromboprophylaxis. Eur J Intern Med. 2023 Nov 28:S0953-6205(23)00414-4. doi: 10.1016/j.ejim.2023.11.017.
	37907305	0	Makedonov I, Kahn S, Abdulrehman J, et al. TILE pilot trial study protocol: Tinzaparin Lead-in to Prevent the Post-Thrombotic syndrome study protocol. BMJ Open. 2023 Oct 31;13(10):e064715. doi: 10.1136/bmjopen-2022-064715.
	37801772	0	Xu Y, Khan F, Kovacs MJ, et al. Serial D-dimers after anticoagulant cessation in unprovoked venous thromboembolism: Data from the REVERSE cohort study. Thromb Res. 2023 Sep 26;231:32-38. doi: 10.1016/j.thromres.2023.09.012.
	37538494	0	Kahn SR, Arnold DM, Casari C, et al. Illustrated State-of-the-Art Capsules of the ISTH 2023 Congress. Res Pract Thromb Haemost. 2023 Jun 21;7(4):100193. doi: 10.1016/j.rpth.2023.100193. eCollection 2023 May.
	37517478	0	Marx CE, Schenker C, Xu Y, et al. Accuracy and interrater agreement of death event adjudications by physician trainees: Validation of the ISTH definition of pulmonary embolism-related death in an autopsy cohort. J Thromb Haemost. 2023 Jul 28:S1538-7836(23)00577-9. doi: 10.1016/j.jtha.2023.07.015.
	37453256	0	Benzidia I, Robitaille C, Abualsaud A, et al. Safety and efficacy of direct oral anticoagulants in patients with chronic thromboembolic pulmonary hypertension. Thromb Res. 2023 Jul 6;229:139-145. doi: 10.1016/j.thromres.2023.07.002.
	37310606	0	Burns KEA, Heels-Ansdell D, Thabane L, et al. Sex differences in thromboprophylaxis of the critically ill: a secondary analysis of a randomized trial. Can J Anaesth. 2023 Jun 13. doi: 10.1007/s12630-023-02457-8.
	37261191	0	Vedantham S, Parpia S, Kahn SR. A Clinical Trial of Venous Stent Placement for Post-thrombotic Syndrome: Current Status and Pandemic-related Changes. Vasc Endovasc Rev. 2022 Feb;5:e06. doi: 10.15420/ver.2021.19. Epub 2022 Jun 21.
	36970743	0	Pop CT, Gu CS, Vedantham S, et al. Exploring the Villalta scale to capture postthrombotic syndrome using alternative approaches: A subanalysis of the ATTRACT trial. Res Pract Thromb Haemost. 2022 Dec 27;7(1):100032. doi: 10.1016/j.rpth.2022.100032. eCollection 2023 Jan.
	36809776	0	Pradier M, Rodger MA, Ghanima W, et al. Performance and head-to head comparison of three clinical models to predict occurrence of post-thrombotic syndrome. A validation study. Thromb Haemost. 2023 Feb 21. doi: 10.1055/a-2039-3388.
	36781052	0	Kahn SR, Matino D, Carrier M, et al. First-Person Call to Attend 2023 Congress. J Thromb Haemost. 2023 Feb 11:S1538-7836(23)00117-4. doi: 10.1016/j.jtha.2023.01.039.
	36710196	0	Caiano L, Kovacs MJ, Lazo-Langner A, et al. The risk of major bleeding in patients with factor V Leiden or prothrombin G20210A gene mutation while on extended anticoagulant treatment for venous thromboembolism. J Thromb Haemost. 2022 Dec 30:S1538-7836(22)19071-9. doi: 10.1016/j.jtha.2022.12.021.
	36186105	0	Koolian M, Wiseman D, Mantzanis H, et al. Anticoagulation stewardship: Descriptive analysis of a novel approach to appropriate anticoagulant prescription. Res Pract Thromb Haemost. 2022 Sep 25;6(6):e12758. doi: 10.1002/rth2.12758. eCollection 2022 Aug.
	36051541	0	Rinfret F, Gu CS, Vedantham S, et al. New and known predictors of the postthrombotic syndrome: A subanalysis of the ATTRACT trial. Res Pract Thromb Haemost. 2022 Aug 29;6(6):e12796. doi: 10.1002/rth2.12796. eCollection 2022 Aug.
	35992565	0	Bistervels IM, Bavalia R, Beyer-Westendorf J, et al. Postthrombotic syndrome and quality of life after deep vein thrombosis in patients treated with edoxaban versus warfarin. Res Pract Thromb Haemost. 2022 Jul 1;6(5):e12748. doi: 10.1002/rth2.12748. eCollection 2022 Jul.
	35803552	0	Thukral S, Salter A, Lancia S, et al. Predictors of Clinical Outcomes of Pharmacomechanical Catheter-Directed Thrombolysis for Acute Iliofemoral Deep Vein Thrombosis - Analysis of a Multicenter Randomized Trial. J Vasc Interv Radiol. 2022 Jul 5. pii: S1051-0443(22)01050-8. doi: 10.1016/j.jvir.2022.05.030.
	35748885	0	Cuker A, Tseng EK, Schunemann HJ, et al. American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: March 2022 update on the use of anticoagulation in critically ill patients Blood Adv. 2022 Jun 24. pii: 485690. doi: 10.1182/bloodadvances.2022007940.
	35679460	0	Wells PS, Tritschler T, Khan F, et al. Predicting major bleeding during extended anticoagulation for unprovoked or weakly provoked venous thromboembolism. Blood Adv. 2022 Jun 9. pii: 485510. doi: 10.1182/bloodadvances.2022007027.
	35587536	0	Popov J, Coelho S, Carrier M, et al. Step down to six months of prophylactic-dose low-molecular-weight heparin after initial full-dose anticoagulation for the treatment of cancer-associated thrombosis (STEP-CAT): a pilot study. J Thromb Haemost. 2022 May 19. doi: 10.1111/jth.15760.
	35503027	0	Cuker A, Tseng EK, Nieuwlaat R, et al. American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of therapeutic-intensity anticoagulation in acutely ill patients. Blood Adv. 2022 May 3. pii: 485124. doi: 10.1182/bloodadvances.2022007561.
	35344784	0	Delluc A, Ghanima W, Kovacs MJ, et al. Prevention of post-thrombotic syndrome with rosuvastatin: A multicenter randomized controlled pilot trial (SAVER). Thromb Res. 2022 Mar 19;213:119-124. doi: 10.1016/j.thromres.2022.03.014.
	35021257	0	Ng S, Rodger MA, Ghanima W, et al. External validation of the patient reported Villalta scale for the diagnosis of post-thrombotic syndrome. Thromb Haemost. 2022 Jan 12. doi: 10.1055/a-1738-1313.
	34852380	0	Makedonov I, Kahn SR, Abdulrehman J, et al. Prevention of the post thrombotic syndrome with anticoagulation: a narrative review. Thromb Haemost. 2021 Dec 1. doi: 10.1055/a-1711-1263.
	34727173	0	Cuker A, Tseng EK, Nieuwlaat R, et al. American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on post-discharge thromboprophylaxis. Blood Adv. 2021 Nov 2. pii: 477753. doi: 10.1182/bloodadvances.2021005945.
	34564938	0	Delluc A, Ghanima W, Kovacs MJ, et al. Statins for venous event reduction in patients with venous thromboembolism: A multicenter randomized controlled pilot trial assessing feasibility. J Thromb Haemost. 2021 Sep 26. doi: 10.1111/jth.15537.
	34518263	0	Galanaud JP, Abdulrehman J, Lazo-Langner A, et al. MUFFIN-PTS trial, Micronized Purified Flavonoid Fraction for the Treatment of Post-Thrombotic Syndrome: protocol of a randomised controlled trial. BMJ Open. 2021 Sep 13;11(9):e049557. doi: 10.1136/bmjopen-2021-049557.
	34474482	0	Cuker A, Tseng EK, Nieuwlaat R, et al. American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patients. Blood Adv. 2021 Oct 26;5(20):3951-3959. doi: 10.1182/bloodadvances.2021005493.
	34351722	0	Goligher EC, Bradbury CA, McVerry BJ, et al. Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19. N Engl J Med. 2021 Aug 26;385(9):777-789. doi: 10.1056/NEJMoa2103417. Epub 2021 Aug 4.
	34351721	0	Lawler PR, Goligher EC, Berger JS, et al. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19. N Engl J Med. 2021 Aug 26;385(9):790-802. doi: 10.1056/NEJMoa2105911. Epub 2021 Aug 4.
	34278193	0	Bavalia R, Bistervels IM, Boersma WG, et al. Quality of life in patients with pulmonary embolism treated with edoxaban versus warfarin. Res Pract Thromb Haemost. 2021 Jul 14;5(5):e12566. doi: 10.1002/rth2.12566. eCollection 2021 Jul.
	34278190	0	Asady E, Ghanima W, Jelsness-Jorgensen LP, et al. Health-related quality-of-life questionnaires for deep vein thrombosis and pulmonary embolism: A systematic review on questionnaire development and methodology. Res Pract Thromb Haemost. 2021 Jul 14;5(5):e12556. doi: 10.1002/rth2.12556. eCollection 2021 Jul.
	34267078	0	Makedonov I, Galanaud JP, Kahn SR. Significance and management of isolated distal deep vein thrombosis. Curr Opin Hematol. 2021 Sep 1;28(5):331-338. doi: 10.1097/MOH.0000000000000670.
	34255928	0	Tritschler T, Salvatore SP, Kahn SR, et al. ISTH definition of pulmonary embolism-related death and classification of the cause of death in venous thromboembolism studies: Validation in an autopsy cohort. J Thromb Haemost. 2021 Oct;19(10):2514-2521. doi: 10.1111/jth.15458. Epub 2021 Aug 1.
	34255420	0	Wik HS, Kahn SR, Eriksson H, et al. Post-thrombotic syndrome in patients with venous thromboembolism treated with dabigatran or warfarin: A long-term cross-sectional follow-up of RE-COVER study patients. J Thromb Haemost. 2021 Oct;19(10):2495-2503. doi: 10.1111/jth.15449. Epub 2021 Jul 28.
	34119655	0	Vedantham S, Salter A, Lancia S, et al. Clinical Outcomes of a Pharmacomechanical Catheter-Directed Venous Thrombolysis Strategy that Included Rheolytic Thrombectomy in a Multicenter Randomized Trial. J Vasc Interv Radiol. 2021 Sep;32(9):1296-1309.e7. doi: 10.1016/j.jvir.2021.06.001. Epub 2021 Jun 11.
	34108229	0	Kovacs MJ, Wells PS, Anderson DR, et al. Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial. BMJ. 2021 Jun 9;373:n1205. doi: 10.1136/bmj.n1205.
	34027293	0	Li KX, Diendere G, Galanaud JP, et al. Micronized purified flavonoid fraction for the treatment of chronic venous insufficiency, with a focus on postthrombotic syndrome: A narrative review. Res Pract Thromb Haemost. 2021 May 8;5(4):e12527. doi: 10.1002/rth2.12527. eCollection 2021 May.
	33992716	0	Wiercioch W, Nieuwlaat R, Dahm P, et al. Development and application of health outcome descriptors facilitated decision-making in the production of practice guidelines. J Clin Epidemiol. 2021 May 13;138:115-127. doi: 10.1016/j.jclinepi.2021.04.016.
	33984268	0	Khan F, Tritschler T, Kahn SR, et al. Venous thromboembolism. Lancet. 2021 Jul 3;398(10294):64-77. doi: 10.1016/S0140-6736(20)32658-1. Epub 2021 May 10.
	33724705	0	Aziz D, Skeith L, Rodger MA, et al. Long-term risk of recurrent venous thromboembolism after a first contraceptive-related event: Data from REVERSE cohort study. J Thromb Haemost. 2021 Jun;19(6):1526-1532. doi: 10.1111/jth.15303. Epub 2021 Apr 21.
	33706398	0	Smith J, Thornhill D, Goldenberg NA, et al. Validation of Outcome Instruments for Pediatric Postthrombotic Syndrome: Introducing the Peds-VEINES-QOL, a New Health-Related Quality of Life Instrument. Thromb Haemost. 2021 Oct;121(10):1367-1375. doi: 10.1055/s-0041-1725199. Epub 2021 Mar 11.
	33560401	0	Cuker A, Tseng EK, Nieuwlaat R, et al. American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19. Blood Adv. 2021 Feb 9;5(3):872-888. doi: 10.1182/bloodadvances.2020003763.
	33548557	0	Lee A, Gu CS, Vedantham S, et al. Performance of two clinical scales to assess quality of life in patients with post-thrombotic syndrome. J Vasc Surg Venous Lymphat Disord. 2021 Sep;9(5):1257-1265.e2. doi: 10.1016/j.jvsv.2021.01.017. Epub 2021 Feb 4.
	33368114	0	Kearon C, Carrier M, Gu CS, et al. Rivaroxaban Compared to Placebo for the Treatment of Leg Superficial Vein Thrombosis: A Randomized Trial. Semin Thromb Hemost. 2020 Nov;46(8):977-985. doi: 10.1055/s-0040-1718891. Epub 2020 Dec 23.
	33134787	0	Galanaud JP, Sevestre MA, Pernod G, et al. Epidemiology and 3-year outcomes of combined oral contraceptive-associated distal deep vein thrombosis. Res Pract Thromb Haemost. 2020 Sep 15;4(7):1216-1223. doi: 10.1002/rth2.12409. eCollection 2020 Oct.
	33049056	0	Darzi AJ, Repp AB, Spencer FA, et al. Risk-assessment models for VTE and bleeding in hospitalized medical patients: an overview of systematic reviews. Blood Adv. 2020 Oct 13;4(19):4929-4944. doi: 10.1182/bloodadvances.2020002482.
	32948386	0	Razavi MK, Salter A, Goldhaber SZ, et al. Correlation between Post-Procedure Residual Thrombus and Clinical Outcome in Deep Vein Thrombosis Patients Receiving Pharmacomechanical Thrombolysis in a Multicenter Randomized Trial. J Vasc Interv Radiol. 2020 Oct;31(10):1517-1528.e2. doi: 10.1016/j.jvir.2020.07.010. Epub 2020 Sep 15.
	32898930	0	Galanaud JP, Ducruet T, Kahn SR. Accuracy of contralateral Villalta score to assess for pre-existing chronic venous insufficiency in patients with unilateral deep vein thrombosis. J Thromb Haemost. 2020 Dec;18(12):3309-3315. doi: 10.1111/jth.15091. Epub 2020 Oct 15.
	32888372	0	Tritschler T, Mathieu ME, Skeith L, et al. Anticoagulant interventions in hospitalized patients with COVID-19: A scoping review of randomized controlled trials and call for international collaboration. J Thromb Haemost. 2020 Nov;18(11):2958-2967. doi: 10.1111/jth.15094. Epub 2020 Oct 1.
	32838111	0	Rosovsky RP, Sanfilippo KM, Wang TF, et al. Anticoagulation Practice Patterns in COVID-19: A Global Survey. Res Pract Thromb Haemost. 2020 Jul 9. pii: RTH212414. doi: 10.1002/rth2.12414.
	32815416	0	Houston BL, Lawler PR, Goligher EC, et al. Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial. Clin Trials. 2020 Oct;17(5):491-500. doi: 10.1177/1740774520943846. Epub 2020 Aug 20.
	32375490	0	Henke PK, Kahn SR, Pannucci CJ, et al. Call to Action to Prevent Venous Thromboembolism in Hospitalized Patients: A Policy Statement From the American Heart Association. Circulation. 2020 Jun 16;141(24):e914-e931. doi: 10.1161/CIR.0000000000000769. Epub 2020 May 7.
	32289163	0	Neumann I, Izcovich A, Zhang Y, et al. DOACs vs LMWHs in hospitalized medical patients: a systematic review and meta-analysis that informed 2018 ASH guidelines. Blood Adv. 2020 Apr 14;4(7):1512-1517. doi: 10.1182/bloodadvances.2019000840.
	32230912	0	Makedonov I, Kahn SR, Galanaud JP. Prevention and Management of the Post-Thrombotic Syndrome. J Clin Med. 2020 Mar 27;9(4). pii: jcm9040923. doi: 10.3390/jcm9040923.
	32211571	0	Kahn SR, Shivakumar S. What's new in VTE risk and prevention in orthopedic surgery. Res Pract Thromb Haemost. 2020 Mar 9;4(3):366-376. doi: 10.1002/rth2.12323. eCollection 2020 Mar.
	32145144	0	Rabinovich A, Gu CS, Vedantham S, et al. External validation of the SOX-PTS score in a prospective multicenter trial of patients with proximal deep vein thrombosis. J Thromb Haemost. 2020 Jun;18(6):1381-1389. doi: 10.1111/jth.14791. Epub 2020 Apr 9.
	32112537	0	Porres-Aguilar M, Kahn SR, Hirsch AM. Direct oral anticoagulants in thrombotic antiphospholipid syndrome associated with chronic thromboembolic pulmonary hypertension. J Thromb Haemost. 2020 Mar;18(3):755-756. doi: 10.1111/jth.14705.
	32110758	0	Dawson AJ, Akaberi A, Galanaud JP, et al. Patient-reported reasons for and predictors of noncompliance with compression stockings in a randomized trial of stockings to prevent postthrombotic syndrome. Res Pract Thromb Haemost. 2019 Dec 29;4(2):269-277. doi: 10.1002/rth2.12296. eCollection 2020 Feb.
	32028109	0	Calais C, Mercier G, Meusy A, et al. Pulmonary embolism home treatment: What GP want? Thromb Res. 2020 Mar;187:180-185. doi: 10.1016/j.thromres.2020.01.015. Epub 2020 Jan 16.
	31983322	0	Garcia MJ, Sterling KM, Kahn SR, et al. Ultrasound-Accelerated Thrombolysis and Venoplasty for the Treatment of the Postthrombotic Syndrome: Results of the ACCESS PTS Study. J Am Heart Assoc. 2020 Feb 4;9(3):e013398. doi: 10.1161/JAHA.119.013398. Epub 2020 Jan 25.
	31917402	0	Kearon C, Kahn SR. Long-term treatment of venous thromboembolism. Blood. 2020 Jan 30;135(5):317-325. doi: 10.1182/blood.2019002364.
	31899848	0	Galanaud JP, Righini M, Le Collen L, et al. Long-term risk of postthrombotic syndrome after symptomatic distal deep vein thrombosis: The CACTUS-PTS study. J Thromb Haemost. 2020 Apr;18(4):857-864. doi: 10.1111/jth.14728. Epub 2020 Feb 11.
	31843251	0	Kahn SR, Julian JA, Kearon C, et al. Quality of life after pharmacomechanical catheter-directed thrombolysis for proximal deep venous thrombosis. J Vasc Surg Venous Lymphat Disord. 2020 Jan;8(1):8-23.e18. doi: 10.1016/j.jvsv.2019.03.023.
	31794602	0	Anderson DR, Morgano GP, Bennett C, et al. American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients. Blood Adv. 2019 Dec 10;3(23):3898-3944. doi: 10.1182/bloodadvances.2019000975.
	31728509	0	Vethanayagam B, Kahn SR. Flying while pregnant: what is the thrombosis risk? J Travel Med. 2020 Mar 13;27(2). pii: 5625777. doi: 10.1093/jtm/taz084.
	31592728	0	Magnuson EA, Chinnakondepalli K, Vilain K, et al. Cost-Effectiveness of Pharmacomechanical Catheter-Directed Thrombolysis Versus Standard Anticoagulation in Patients With Proximal Deep Vein Thrombosis: Results From the ATTRACT Trial. Circ Cardiovasc Qual Outcomes. 2019 Oct;12(10):e005659. doi: 10.1161/CIRCOUTCOMES.119.005659. Epub 2019 Oct 8.
	31129575	0	Kahn SR, Diendere G, Morrison DR, et al. Effectiveness of interventions for the implementation of thromboprophylaxis in hospitalised patients at risk of venous thromboembolism: an updated abridged Cochrane systematic review and meta-analysis of randomised controlled trials. BMJ Open. 2019 May 24;9(5):e024444. doi: 10.1136/bmjopen-2018-024444.
	30699446	0	Kearon C, Gu CS, Julian JA, et al. Pharmacomechanical Catheter-Directed Thrombolysis in Acute Femoral-Popliteal Deep Vein Thrombosis: Analysis from a Stratified Randomized Trial. Thromb Haemost. 2019 Apr;119(4):633-644. doi: 10.1055/s-0039-1677795. Epub 2019 Jan 30.
	30656824	0	Righini M, Robert-Ebadi H, Glauser F, et al. Effect of anticoagulant treatment on pain in distal deep vein thrombosis: an ancillary analysis from the cactus trial. J Thromb Haemost. 2019 Mar;17(3):507-510. doi: 10.1111/jth.14387. Epub 2019 Feb 3.
	30586751	0	Comerota AJ, Kearon C, Gu CS, et al. Endovascular Thrombus Removal for Acute Iliofemoral Deep Vein Thrombosis. Circulation. 2019 Feb 26;139(9):1162-1173. doi: 10.1161/CIRCULATIONAHA.118.037425.
	30482763	0	Schunemann HJ, Cushman M, Burnett AE, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients. Blood Adv. 2018 Nov 27;2(22):3198-3225. doi: 10.1182/bloodadvances.2018022954.
	30349885	0	Ma KA, Kahn SR, Akaberi A, et al. Serial imaging after pulmonary embolism and correlation with functional limitation at 12 months: Results of the ELOPE Study. Res Pract Thromb Haemost. 2018 Jun 17;2(4):670-677. doi: 10.1002/rth2.12123. eCollection 2018 Oct.
	30080513	0	Murad MH, Kahn SR. Response. Chest. 2018 Aug;154(2):460-461. doi: 10.1016/j.chest.2018.04.042.
	29789147	0	Galanaud JP, Blaise S, Sevestre MA, et al. Long-term outcomes of isolated superficial vein thrombosis in patients with active cancer. Thromb Res. 2018 Nov;171:179-186. doi: 10.1016/j.thromres.2018.04.013. Epub 2018 Apr 20.
	29742368	0	Anderson DR, Doucette S, Kahn SR. Venous Thromboembolism Prophylaxis after Hip or Knee Arthroplasty. N Engl J Med. 2018 May 10;378(19):1848-1849. doi: 10.1056/NEJMc1803708.
	29687454	0	Kahn SR, Morrison DR, Diendere G, et al. Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism. Cochrane Database Syst Rev. 2018 Apr 24;4:CD008201. doi: 10.1002/14651858.CD008201.pub3.
	29545327	0	Rabinovich A, Kahn SR. How I treat the postthrombotic syndrome. Blood. 2018 May 17;131(20):2215-2222. doi: 10.1182/blood-2018-01-785956. Epub 2018 Mar 15.
	29466159	0	Anderson DR, Dunbar M, Murnaghan J, et al. Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty. N Engl J Med. 2018 Feb 22;378(8):699-707. doi: 10.1056/NEJMoa1712746.
	29459016	0	Kahn SR, Pengo V. Special issue: Late consequences of venous thromboembolism. Thromb Res. 2018 Apr;164:99. doi: 10.1016/j.thromres.2018.02.005. Epub 2018 Feb 13.
	29407624	0	Rodger M, Langlois N, Middeldorp S, et al. Initial strides for invent-VTE: Towards global collaboration to accelerate clinical research in venous thromboembolism. Thromb Res. 2018 Mar;163:128-131. doi: 10.1016/j.thromres.2018.01.050. Epub 2018 Jan 31.
	29378357	0	Galanaud JP, Bertoletti L, Amitrano M, et al. Predictors of Post-Thrombotic Ulcer after Acute DVT: The RIETE Registry. Thromb Haemost. 2018 Feb;118(2):320-328. doi: 10.1160/TH17-08-0598. Epub 2018 Jan 29.
	29224973	0	Wan T, Rodger M, Zeng W, et al. Residual pulmonary embolism as a predictor for recurrence after a first unprovoked episode: Results from the REVERSE cohort study. Thromb Res. 2018 Feb;162:104-109. doi: 10.1016/j.thromres.2017.11.020. Epub 2017 Dec 8.
	29211671	0	Vedantham S, Goldhaber SZ, Julian JA, et al. Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis. N Engl J Med. 2017 Dec 7;377(23):2240-2252. doi: 10.1056/NEJMoa1615066.
	29126608	0	Wik HS, Enden TR, Ghanima W, et al. Diagnostic scales for the post-thrombotic syndrome. Thromb Res. 2018 Apr;164:110-115. doi: 10.1016/j.thromres.2017.10.022. Epub 2017 Oct 28.
	28942356	0	Ikesaka RT, Kahn SR, Galanaud JP, et al. The importance of post thrombotic syndrome as an outcome after deep venous thrombosis: A survey of Canadian thrombosis clinicians. Thromb Res. 2017 Nov;159:13-15. doi: 10.1016/j.thromres.2017.09.015. Epub 2017 Sep 15.
	28844444	0	Galanaud JP, Monreal M, Kahn SR. Epidemiology of the post-thrombotic syndrome. Thromb Res. 2018 Apr;164:100-109. doi: 10.1016/j.thromres.2017.07.026. Epub 2017 Jul 24.
	28470653	0	Wik HS, Ghanima W, Sandset PM, et al. Scoring Systems for Postthrombotic Syndrome. Semin Thromb Hemost. 2017 Jul;43(5):500-504. doi: 10.1055/s-0037-1599142. Epub 2017 May 3.
	28320004	0	Kahn SR. Review: Thrombolysis for DVT reduces postthrombotic syndrome but increases bleeding complications. Ann Intern Med. 2017 Mar 21;166(6):JC30. doi: 10.7326/ACPJC-2017-166-6-030.
	28314711	0	Rodger MA, Le Gal G, Anderson DR, et al. Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study. BMJ. 2017 Mar 17;356:j1065. doi: 10.1136/bmj.j1065.
	27913509	0	Kahn SR. The post-thrombotic syndrome. Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):413-418. doi: 10.1182/asheducation-2016.1.413.
	27836513	0	Righini M, Galanaud JP, Guenneguez H, et al. Anticoagulant therapy for symptomatic calf deep vein thrombosis (CACTUS): a randomised, double-blind, placebo-controlled trial. Lancet Haematol. 2016 Dec;3(12):e556-e562. doi: 10.1016/S2352-3026(16)30131-4. Epub 2016 Nov 8.
	27639012	0	Galanaud JP, Monreal M, Kahn SR. Predictors of the post-thrombotic syndrome and their effect on the therapeutic management of deep vein thrombosis. J Vasc Surg Venous Lymphat Disord. 2016 Oct;4(4):531-4. doi: 10.1016/j.jvsv.2015.08.005. Epub 2016 Jan 7.
	27318246	0	Ma K, Wells P, Guzman C, et al. A multicenter prospective study of risk factors and treatment of unusual site thrombosis. Thromb Res. 2016 Aug;144:100-5. doi: 10.1016/j.thromres.2016.04.014. Epub 2016 Apr 26.
	27247235	0	Vedantham S, Kahn SR, Goldhaber SZ, et al. Endovascular therapy for advanced post-thrombotic syndrome: Proceedings from a multidisciplinary consensus panel. Vasc Med. 2016 Aug;21(4):400-7. doi: 10.1177/1358863X16650747. Epub 2016 May 30.
	27096813	0	Rodger MA, Phillips P, Kahn SR, et al. Low molecular weight heparin to prevent postpartum venous thromboembolism: A pilot study to assess the feasibility of a randomized, open-label trial. Thromb Res. 2016 Jun;142:17-20. doi: 10.1016/j.thromres.2016.04.004. Epub 2016 Apr 9.
	27086275	0	Rodger MA, Scarvelis D, Kahn SR, et al. Long-term risk of venous thrombosis after stopping anticoagulants for a first unprovoked event: A multi-national cohort. Thromb Res. 2016 Jul;143:152-8. doi: 10.1016/j.thromres.2016.03.028. Epub 2016 Mar 29.
	26992609	0	Rabinovich A, Cohen JM, Cushman M, et al. Association between inflammation biomarkers, anatomic extent of deep venous thrombosis, and venous symptoms after deep venous thrombosis. J Vasc Surg Venous Lymphat Disord. 2015 Oct;3(4):347-353.e1. doi: 10.1016/j.jvsv.2015.04.005. Epub 2015 Aug 1.
	26947569	0	Sabapathy CA, Djouonang TN, Kahn SR, et al. Incidence Trends and Mortality from Childhood Venous Thromboembolism: A Population-Based Cohort Study. J Pediatr. 2016 May;172:175-180.e1. doi: 10.1016/j.jpeds.2016.02.017. Epub 2016 Mar 3.
	26819144	0	Tagalakis V, Eberg M, Kahn S, et al. Use of statins and reduced risk of recurrence of VTE in an older population. A population-based cohort study. Thromb Haemost. 2016 Jun 2;115(6):1220-8. doi: 10.1160/TH15-10-0775. Epub 2016 Jan 28.
	26780743	0	Kahn SR, Galanaud JP, Vedantham S, et al. Guidance for the prevention and treatment of the post-thrombotic syndrome. J Thromb Thrombolysis. 2016 Jan;41(1):144-53. doi: 10.1007/s11239-015-1312-5.
	26422814	0	Utne KK, Ghanima W, Foyn S, et al. Development and validation of a tool for patient reporting of symptoms and signs of the post-thrombotic syndrome. Thromb Haemost. 2016 Jan;115(2):361-367. doi: 10.1160/th15-04-0318. Epub 2015 Sep 17.
	25755227	0	Kahn SR, Shapiro S. Response. Clin Trials. 2015 Apr;12(2):178. doi: 10.1177/1740774515569012.
	25373438	0	Rodger MA, Phillips P, Kahn SR, et al. Low-molecular-weight heparin to prevent postpartum venous thromboembolism. A pilot randomised placebo-controlled trial. Thromb Haemost. 2015 Jan;113(1):212-6. doi: 10.1160/TH14-06-0485. Epub 2014 Nov 6.